European Human Genetics. Conference 2014, Milan, İtalya, 31 Mayıs - 03 Haziran 2014, cilt.22, sa.1, ss.215
Craniosynostosis(CS) is a birth defect, with a prevalence of 1/2100-1/2500,
caused by the premature fusion of one or more cranial sutures leading to
speciic cranial base and vault abnormalities. It is a highly heterogeneous
group of disorders occurring both in syndromic and non-syndromic forms,
associated with approximately 180 different syndromes. The identiication
of the responsible gene largely depends on the fact if it is syndromic
or non-syndromic. Although 85% of the cases are reported to be non-syndromic
with unknown etiology, syndromic forms arise from chromosomal
anormalies or single gene defects of Mendelian inheritance, both together
comprising the etiopathogenesis only in 40% of the cases and single gene
defects contributing to three/fourth. Noteworthy genes in this group are
FGFR1, FGFR2, FGFR3, TWIST1, EFNB1, MSX2, RAB23 and FREM1. EFNB1
can be excluded from this group due to its association with Craniofrontonasal
Syndrome. Thirty syndromic CS patients with normal karyotype were
included in the study cohort. Stepwise screening algorithm was applied, initial
step being the sequencing of FGFR2, FGFR3 and FGFR1, followed by full
gene sequencing of FGFR2 and FGFR3. Samples with unidentiied etiology
were further screened for deletion/duplication by craniofrontonasal MLPA
kit (P080). The last step consisted of sequencing of FGFR1, MSX2, TWIST1,
RAB23 and FREM1 genes, when the cases showed distinct related clinical
phenotype.
We highly suggest that our ongoing research will lead to better insight for
the clinical diagnosis, molecular diagnostic low charts in CS and will contribute
to the genotype-phenotype correlation.